Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE1
INTERVENTIONAL
2013-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Computer Adaptation of Screening, Brief MET Intervention to Reduce Teen Drinking
NCT01881841
Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use
NCT01796158
Development and Testing of Adolescent Twelve-Step Facilitation
NCT01449981
Medical Office Intervention for Adolescent Drug Use
NCT00229983
Reducing Problematic Substance Use in Youth With Chronic Medical Conditions
NCT01709201
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment as Usual
Patients will receive the usual care from the treatment program
No interventions assigned to this group
iMET
Participants will complete a self-guided computerized Motivational Enhancement Therapy
iMET
Self-completed, computerized motivational enhancement therapy
MET
Clinician-delivered Motivational Enhancement Therapy
MET
Clinician-delivered Motivational Enhancement Therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iMET
Self-completed, computerized motivational enhancement therapy
MET
Clinician-delivered Motivational Enhancement Therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be available to return for iMET/MET sessions (if assigned)
* be available to complete all follow-up measurements
* a past-12-month CRAFFT score \>1
* have used substances on \>6 days (not including tobacco use) during the 90 days preceding their visit
Exclusion Criteria
* youth deemed by the clinical team to require immediate hospitalization or referral to more intensive residential treatment
12 Years
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sion Kim Harris
Co-Director, Center for Adolescent Substance Abuse Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sion K Harris, PhD
Role: PRINCIPAL_INVESTIGATOR
Boston Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston Children's Hospital
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SKH R01 PA-13-077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.